Skip to content

Clinical trials

Phase 2 Lymphoproliferative Disorders trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 2 Country / region: Spain Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20112
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen Research (Munich) GmbH2
Cellectar Biosciences, Inc.1
European Association of Urology Research Foundation1
Pierre Fabre Medicament1
Seagen Inc.1
miRagen Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders7
Immunoproliferative Disorders4
Lymphatic Diseases4
Lymphoma3
Lymphoma, Non-Hodgkin3
Hematologic Diseases2
Immune System Diseases2
Leukemia2
Lymphoma, Large B-Cell, Diffuse2
Neoplasms2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.